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ABSTRACT
Objective Cardiac MRI is quickly emerging as the gold 
standard for assessment of mitral regurgitation, most 
commonly with the indirect method subtracting forward 
flow in aorta from volumetric segmentation of the left 
ventricle. We aimed to investigate how aortic flow 
measurements with increasing distance from the aortic 
valve affect calculated mitral regurgitations and whether 
measurements were influenced by breath- hold regimen.
Methods Free- breathing and breath- hold phase contrast 
flows were measured in aorta at valve level, sinotubular 
(ST) junction, mid- ascending aorta and in the pulmonary 
trunk. Flow measurements were pairwise compared, and 
subsequently, after exclusion of patients with visible mitral 
and tricuspid regurgitations for left- sided and right- sided 
comparisons, respectively, flow- measured stroke volumes 
were compared with ventricular volumetric segmentations.
Results Thirty- nine participants without arrhythmias 
or structural abnormalities of the large vessels were 
included. Stroke volumes measured with free- breathing 
and breath- hold flow decreased equally with increasing 
distance to the aortic valves (breath- hold flow: aortic 
valve 105.6±20.8 mL, ST junction 101.5±20.7 mL, 
mid- ascending aorta 98.1±21.5 mL). After exclusion of 
atrioventricular regurgitations, stroke volumes determined 
by volumetric measurements were higher compared with 
values determined by flow measurements, corresponding 
to ‘false’ atrioventricular regurgitations of 8.0%±5.8% 
with flow measured at valve level, 11.6%±5.2% at the ST 
junction and 15.3%±5.0% at the mid- ascending aorta.
Conclusions Stroke volumes determined by flow 
decrease throughout the proximal aorta and are 
systematically lower than volumetrically measured stroke 
volumes. The indirect method systematically overestimates 
mitral regurgitations, especially with increasing distance 
from the aortic valves.
INTRODUCTION
Cardiovascular magnetic resonance imaging 
(CMR) is the gold standard for measuring 
volumes in the heart and is widely used for 
this purpose in research and clinical practice. 
Mitral regurgitations can be assessed by CMR 
with the indirect method by subtracting the 
forward phase contrast (PC) flow in aorta 
from the detailed volumetric segmentation of 
the left ventricle.1 A recent review2 highlights 
CMR as superior to 2D and 3D echocardiog-
raphy in quantification of mitral regurgita-
tions and advocates the use of CMR in future 
studies and clinical assessments. Despite 
its many advantages, CMR is also subject to 
method- specific errors and it is essential that 
these limitations are known and taken into 
account when reporting CMR- derived meas-
urements.3
CMR studies have shown that stroke 
volume (SV) determined in the ascending 
aorta with 2D PC flow in healthy controls 
decrease the more distally in the ascending 
Key questions
What is already known about this subject?
 ► The indirect method for quantification of mitral re-
gurgitations is reproducible and superior to echo-
cardiographic methods. Literature suggests that 
stroke volumes measured with phase contrast flow 
in aorta decrease with increasing distance from the 
aortic valve, but there is no consensus on where to 
measure flow in aorta and how choice of level im-
pacts calculated mitral regurgitations by the indirect 
method.
What does this study add?
 ► In participants with no structural abnormalities of 
the large vessels, stroke volumes measured with 
flow in aorta decreases with increasing distance 
from the aortic valves and stroke volumes are sys-
tematically lower when compared with volumetric 
measurements irrespective of breath- hold regimen. 
This results in an overestimation of calculated mi-
tral regurgitations when using the indirect method 
ranging from 8% at the aortic valve level, 12% at the 
sinotubular junction and 15% in the mid- ascending 
aorta.
How might this impact on clinical practice?
 ► A clear indication of the level of measurement 
should always be reported for clinicians to assess 
how measurement method could possibly affect 
results. Choice of distal level of measurement may 
result in overestimation of mitral regurgitations.
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aorta the measurement is performed,4 5 and the phenom-
enon is even more pronounced under pathological 
conditions.5–8 While a recent consensus statement recom-
mends measuring forward aortic volume at the level of 
the sinotubular (ST) junction,9 different measurement 
locations in the aorta are regularly used (table 1). In 
some studies, measurements from different locations are 
used indiscriminately,10 and some studies do not report 
the location of flow measurement.11–13
Furthermore, studies have found a systematic differ-
ence, with volumetrically segmented SV being several 
millilitres greater than SV based on flow measure-
ments.8 14 15 Consequently, this may result in systematic 
overestimation of calculated atrioventricular regurgi-
tations. Theoretically, this could be caused by different 
breath- hold regimens between volumetric and flow 
measurements.16 It has been suggested that, if performed 
correctly, free- breathing and breath- hold PC flow can be 
used interchangeably7 17 while others disagree.4
The aim of this study was to quantify the impact of 
changing image planes between the most frequently used 
locations in aortic flow measurements. Second is to eval-
uate the impact of breath- hold regimen as well as eval-
uate the corresponding ‘false’ regurgitant volume with 
the indirect method. To provide a best- case scenario, the 
study was performed in subjects with no abnormalities of 
the large vessels.
METHODS
Participants were recruited from a clinical study including 
patients with known paroxysmal atrial fibrillation and a 
healthy control group from October to December 2017. 
All included participants had a full CMR and no previ-
ously known structural heart disease. Participants were 
excluded if they could not comply with instructions, 
experienced arrythmia during the scan, if CMR revealed 
pathological conditions of valves or vessels of interest, or 
if any flow measurements were of unacceptable quality.
All participants were at least 18 years of age and signed 
informed written consent prior to scanning. Patient or 
public involvement was not considered appropriate.
Image acquisition
All scans were performed on a 1.5 T Siemens Aera 
(Erlangen, Germany) and corresponded to normal clin-
ical scans.
Long- axis cine images (two- chamber, three- chamber 
and four- chamber) were acquired initially. Volumetric 
measurements were performed with SSFP cine sequences 
Table 1 Overview of studies on assessment of mitral regurgitation with CMR
First author and reference Year n Reported level of measurement
Hundley et al1 1995 17 2 to 4 cm above the aortic valve
Kizilbash et al 1998 22 Ascending aorta, well above the aortic valve and coronary ostia
Gelfand et al 2006 83 The axial plane at the level of the bifurcation of the pulmonary artery
Buck et al 2008 73 Orthogonal to the mid- ascending aorta
Uretsky et al12 2010 23 Not reported
Myerson et al10 2010 55 Just above the aortic valve
Shanks et al 2010 30 2 to 5 cm above the aortic valve, where the aorta was nearly parallel to the caudal 
cranial axis of the patient, in the axial orientation
Hamada et al 2012 43 10 mm above the tip of the aortic valve
Cawley et al 2013 26 Aortic valve
Van De Heyning et al 2013 38 Ascending aorta
Thavendiranathan et al 2013 30 1 to 2 cm above the aortic valve
Choi et al 2014 52 2 to 3 cm above the aortic valve
Uretsky et al11 2015 103 Not reported
Sachdev et al13 2017 58 Not reported
Lopez- Mattei et al 2016 70 Sinotubular junction
Aplin et al22 2016 72 Sinotubular junction
Myerson et al23 2016 109 Just above the aortic valve at end diastole or at the sinotubular junction
Harris et al 2017 22 Across the aortic valve
Polte et al 2017 40 Sinotubular junction
Heo et al 2017 37 2 to 3 cm above the aortic valve
Penicka et al24 2018 258 2 to 3 cm above the aortic valve
Chew et al30 2019 109 At the aortic sinotubular junction or just above the valve prosthesis post- replacement
CMR, cardiac magnetic resonance imaging.
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Valvular heart disease
(typical imaging parameters: 8 mm slice thickness; 2 mm 
gap; pixel size 1.9×1.9 mm; 25 phases; TR/TE 2.6/1.1 
ms) during end- expiratory breath- holds. An axial stack 
ranging from basis to the aortic arch and a short- axis 
stack covering the entire left ventricle were obtained.
Flow (through plane phase contrast) sequences 
corresponding to normal clinical flow sequences 
were performed. A free- breathing (FB) and a breath- 
hold (BH) sequence were performed at each plane as 
depicted in figure 1: in the pulmonary trunk (PA) and 
at three levels in the aorta. For measurements at aortic 
valve level (Va), the imaging plane was placed at the tip 
of the open aortic valve leaflets in systole always proximal 
to the coronary arteries. At the ST junction, the imaging 
slice was placed just distal to the aortic sinus. At the mid- 
ascending aorta, the slice in the axial stack displaying the 
pulmonary bifurcation was copied without corrections 
to the flow sequence as described in the literature.18 For 
positioning of all flow planes (except the mid- ascending 
aorta) perpendicularly to the vessels, two orthogonal 
images were obtained. Imaging parameters for the two 
flow sequences are reported in table 2. To minimise 
phase offset errors, vessels were placed along the z- axis as 
close to the isocentre as possible. Velocity encoding was 
set to 200 cm/s.
Image analyses
All images were analysed in CVI42 V.5.6.6 (Circle Cardi-
ovascular Imaging). On short- axis cine images, left 
ventricular (LV) end- diastolic and end- systolic phases 
were traced manually at the endocardial and epicardial 
border. LV outflow tract was included in the blood pool; 
papillary muscles were excluded, using windowing for the 
endocardial border. Epicardium was delineated in both 
phases to compare left myocardial mass in end- diastole 
and end- systole. The right ventricle was traced manually 
on axial cine images in end- diastolic and end- systolic 
phases and trabeculation was included in the blood pool. 
Right ventricular outflow tract was included in the blood 
pool. Cross- sectional images of valves were carefully 
referenced to determine distinction between ventricular 
blood pool and atrial and vascular blood pool.
Flow sequences were measured semi- automated with 
manual correction, carefully tracing the outer vessel 
wall. Images and flow curves were assessed for signs of 
arrhythmia during scanning and aliasing. As we wanted 
the setting to be as similar to a clinical workflow as possible, 
we did not perform phantom corrections. Background 
correction was performed on all uniform muscle tissue 
in the magnitude image.15 19 Forward flow, representing 
SV, was registered for all images (pulmonary artery, aorta 
at valve level, ST junction and mid- ascending aorta with 
breath- hold and free- breathing sequences, respectively). 
Heart rate for each sequence was registered. Peak velocity 
for each flow measurement was registered in 2×2 pixels 
to avoid errors on pixel level.20 Qp/Qs ratios were calcu-
lated as pulmonary SV measured with PC flow divided by 
systemic SV measured with PC flow at different levels in 
the aorta.
The axial cine stack and two- chamber, three- chamber 
and four- chamber cine images were visually inspected for 
mitral and tricuspid regurgitations. The flow measure-
ments were not taken into consideration when assessing 
valvular regurgitation.
Statistics
All data are reported as means and SD unless stated 
otherwise. Paired t- tests were performed to compare flow 
measurements. P values less than 0.05 were considered 
statistically significant.
Figure 1 Illustration of included flow measurements. (A, 
B) Three- chamber and orthogonal cine images showing 
levels of flow measurements in aorta at valve level (green 
line), sinotubular junction (red line) and mid- ascending 
aorta (yellow line). (C, D) Right ventricular outflow tract and 
pulmonary trunk and orthogonal cine images showing level 
of flow measurement in the pulmonary artery (blue line). Ao, 
aorta; LA, left atrium; LV, left ventricle; PA, pulmonary artery/
trunk; RV, right ventricle.
Table 2 Acquisition parameters for phase contrast flow 
sequences
Breath- hold Free- breathing
TR/TE (ms) 4.64/2.47 5.09/2.8
Flip angle (°) 20 20
Bandwidth (Hz/pixel) 450 455
Slice thickness (mm) 6 5
Matrix size (voxels) (126–192)×(126–256) (168–256)×(176–256)
Pixel size (mm) 1.77×1.77 1.33×1.33
Frames/cycle 30 50
Typical acquisition 
time (s)
13–17 150–180
Averages 1 3
TE, echo time; TR, repetition time.
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First, to assess the effect of breathing regimen, flow 
assessments with FB and BH sequences were compared 
for each imaging level with paired t- tests and Bland- 
Altman plots were constructed.21 Due to the flow in the 
coronary arteries, flow comparisons were limited to flow 
in aorta at valve level versus the pulmonary artery and in 
aorta at ST junction versus mid- ascending aorta. Bland- 
Altman plots were visually inspected for trumpet shapes 
as a sign of increasing effect with increasing SV.
Subsequently, for assessment of a possible bias 
when calculating mitral regurgitations with the indi-
rect method, differences between flow and volumetric 
measurements were compared with paired t- tests and 
Bland- Altman plots. In this second analysis, partici-
pants with visible mitral or tricuspid regurgitations were 
excluded from left- sided and right- sided measurements, 
respectively. The resulting ‘false’ regurgitant volume was 
calculated for each measurement.
RESULTS
Initially, 50 participants were included. Three participants 
were excluded due to frequent premature ventricular 
contractions. Three participants were excluded due to 
inability to comply with BH instructions. Two participants 
were excluded due to bicuspid aortic valves (not previ-
ously known). Three participants were excluded due to 
a single flow measurement of unacceptable quality (two 
FB valve flows due to inability to make a precise delin-
eation of the valve because of too much blurring and 
one BH pulmonary flow due to wrap over the artery, not 
noticed during the scan). Consequently, 39 participants 
with no abnormalities of the large vessels and complete 
flow measurements were included in the analyses. Nine 
participants had visible mitral regurgitation. Thirteen 
had visible tricuspid regurgitation. Baseline characteris-
tics of participants are reported in table 3.
BH regimens
There were no statistical differences between FB and BH 
flows, except at valve level (table 4). As summarised in 
online supplementary table S1, background correction 
changed FB more than BH sequences, hence FB and 
BH flow measurements before background correction 
were statistically different. Bland- Altman plots of FB flow 
compared with BH flow showed no increased difference 
with increasing SV (online supplementary figure S1). 
The limits of agreement were ±14.3 mL for the pulmo-
nary artery while similar for all aorta flows (valve ±9.9 mL, 
ST junction ±10.4 mL and mid- ascending ±9.9 mL), and 
all showed none to very small bias from zero.
Comparisons of peak velocities, heart rates and arte-
facts between FB and BH sequences are reported in 
online supplementary material.
Flow signal in the aortic root
Table 4 summarises the SV measured at the three 
different levels in the aortic root and in the main pulmo-
nary artery. A decrease in aortic flow volume was seen with 
increasing distance to the valve. Figure 2 depicts how this 
was directly evident in the majority of the participants. A 
decrease of 5% would be expected between aortic valve 
and ST junction, due to coronary flow, but the additional 
decrease between ST junction and mid- ascending aorta 
was also statistically significant. The corresponding Qp/
Qs ratios also increased with increasing distance from the 
valves (table 4).
Bias between flow and volumetric measurements
Figure 3 shows Bland- Altman plots for FB and BH flow 
measurements compared with corresponding volumetric 
measurements. In these comparisons, participants with 
visible mitral regurgitations (for left- sided comparisons) 
and tricuspid regurgitations (for right- sided comparison) 
have been excluded and therefore the volumetric meas-
urements should theoretically be equal to SV measured 
with flow, though 5% lower when measured in the aorta 
distal to the coronary arteries. Nevertheless, we found a 
bias between volumetric measurements and BH flow SV 
increasing from 10.6 mL on valve level to 14.0 mL on ST 
junction and further to 17.7 mL in mid- ascending aorta. 
On the right side, a mean difference of 4.8 mL was found. 
Comparisons with FB showed similar results for ST junc-
tion (15.3 mL) and mid- ascending aorta (17.8 mL) but a 
smaller bias at valve level (6.4 mL) (online supplemen-
tary table S2).
In clinical assessment of mitral or tricuspid regurgi-
tations, the found bias would, employing the indirect 
method, result in a ‘false’ regurgitant volume as presented 
Table 3 Baseline characteristics of included patients
N 39
Age, years (IQR) 42.5 (38.6–45.1)
Height, cm (SD) 182.2 (8.6)
Weight, kg (SD) 86.1 (11.4)
Male sex, n (%) 32 (82)
Hypertension, n (%) 3 (2 without treatment) (8)
Diabetes mellitus, n (%) 0 (0)
Ischaemic heart disease, n (%) 0 (0)
Paroxysmal atrial fibrillation, n (%) 26 (67)
LV EDV, mL/m2 (SD) 92.5 (14.7)
LV ESV, mL/m2 (SD) 37.7 (7.8)
LV SV, mL/m2 (SD) 54.9 (9.2)
LV EF (%) 59.4 (5.0)
LV myocardial mass (diastole), g/
m2 (SD)
62.4 (11.0)
RV EDV, mL/m2 (SD) 96.9 (17.2)
RV ESV, mL/m2 (SD) 43.1 (9.1)
RV SV, mL/m2 (SD) 53.7 (9.7)
RV EF (%) 55.6 (4.4)
Values are shown as mean (SD) or median (IQR).
EDV, end- diastolic volume; EF, ejection fraction; ESV, end- systolic 
volume; LV, left ventricle; RV, right ventricle; SV, stroke volume.
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in figure 4. This overestimated volume resulted in calcu-
lated regurgitation fractions in healthy young partici-
pants with no visible regurgitation of 8.0% (SD 5.8) for 
BH measurements at valve level, 11.6% (SD 5.2) at the ST 
junction, 15.3% (SD 5.0) at the mid- ascending aorta and 
3.8% (SD 8.3) in the pulmonary artery.
DISCUSSION
This study demonstrates fundamental problems in assess-
ment of mitral regurgitation using the most commonly 
applied CMR approach. Our study shows that in subjects 
with no abnormalities of the large arteries, CMR 
2D PC flow measurements decrease from the aortic 
valve throughout the aortic root and ascending aorta. 
Compared with volumetric measurements, flow meas-
urements underestimate SV. This difference results in 
a calculated ‘false’ atrioventricular regurgitant volume 
when applying the most common method for assessing 
mitral regurgitations, the indirect method. Calculated 
mitral regurgitations increased from 8% at valve level to 
15% in the mid- ascending aorta. The difference was not 
affected by different BH regimens.
As described in recent reviews,2 3 CMR quantification 
of mitral regurgitation is reproducible and has shown 
its superiority compared with other methods in large 
studies.11 22–24 Even though quantification of aortic flow 
is essential to the indirect CMR assessment of regurgita-
tions, some of these studies use the different measure-
ment planes equally or do not report the location of the 
aortic flow measurement (table 1). Hence, based on the 
results from the present study, these studies may have 
overestimated calculated mitral regurgitations by up to 
15%. Because the conditions in the present study repre-
sent a best- case scenario, the actual overestimation is 
possibly even larger.
Mitral regurgitation assessments with the indirect method
A different issue with the indirect quantification method 
is the combination of two different means of measure-
ment, the volumetric segmentation and the forward flow 
measurement. First, the measurements are not performed 
simultaneously and a change in cardiac output during 
the scan, which is not uncommon due to initial patient 
nervousness associated with being in the scanner and 
Figure 2 Individual flow measurements in aorta. Stroke 
volumes measured with phase contrast flow at indicated 
levels in the aortic root (valve, ST junction and mid- 
ascending). (A) Free- breathing flow measurements. (B) 
Breath- hold flow measurements. Red line indicates mean 
values. Notice how measured stroke volumes decrease with 
increasing distance to the valve. ST, sinotubular.
Table 4 Mean stroke volumes measured in aorta and in the main pulmonary artery and corresponding Qp/Qs ratios
n=39 FB BH
P value
FB vs BH
Valve level
  Stroke volume, mL (SD) 107.5 (20.2) 104.1 (19.6) <0.001
  Qp/Qs, mean (range) 0.98 (0.78–1.10) 1.02 (0.85–1.21)
ST- junction level
  Stroke volume, mL (SD) 99.1 (20.2) 99.9 (20.2) 0.3
  Qp/Qs, mean (range) 1.06 (0.89–1.29) 1.07 (0.96–1.23)
Mid- ascending aorta
  Stroke volume, mL (SD) 96.2 (20.8) 96.2 (20.6) 1.0
  Qp/Qs, mean (range) 1.10 (0.94–1.21) 1.11 (0.91–1.29)
Pulmonary artery
  Stroke volume, mL (SD) 104.5 (21.1) 106.0 (20.5) 0.2
P values for flow vs flow
Valve vs pulmonary 0.02 0.1
ST junction vs mid- ascending 0.01 <0.001
P values for paired t- tests between stroke volumes.
Qp/Qs should be 1 before the coronary arteries (valve level) and 1.05 after the coronary arteries (ST junction and mid- ascending aorta).
BH, breath- hold; FB, free- breathing; Q, flow rate; Qp/Qs, pulmonary flow divided by systemic flow; ST junction, sinotubular junction.
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subsequent accommodation to the unfamiliar environ-
ment, often results in a fall in cardiac output. Second, 
reproducibility tests of PC flow have shown high consist-
ency of mean values and when analyses are repeated on 
the same images or images are repeated on the same 
patient, the SV measured with PC flow vary, typically in 
the range of ±10–15 mL.4 12 25 The volumetric measure-
ments also provide high reproducibility in the range of 
approximately ±10 mL.26 Therefore, calculations of mitral 
regurgitations combining a volumetric and a flow meas-
urement increase the variation and a true value should 
be expected within approximately ±20–25 mL. Hence, 
studies on many patients may provide high reproduci-
bility and precision, but in clinical praxis we often struggle 
with variation in measurements and how to interpret the 
results for the individual patient. This issue is highlighted 
by Gulsin et al27 stating that it is not uncommon that meas-
ured flow is higher at the ST junction compared with 
valve level even though the opposite would be expected 
due to the position of the coronary arteries between the 
two locations. This is also evident in figure 2 where flow 
SV of a few participants are not decreasing throughout 
the aortic root as it is for the majority. This may in part 
be due to the variation seen in flow measurements and of 
course be due to the fact that PC flow is very susceptible 
to artefacts and arrhythmias.28 29
To further complicate matters, in contrast to the pres-
ently found underestimation of forward flow in aorta 
when compared with volumetric assessment, the pres-
ence of aortic stenoses and hence high flow velocities 
often result in overestimation of forward flow in aorta.8 30 
Thus, in this context, the indirect method may result in 
underestimation of possible mitral regurgitations, which 
is often coexisting with aortic stenosis.30
The indirect method furthermore relies on the volu-
metric assessment as reference. Despite being the gold 
standard,18 this method has several limitations. Results 
of volumetric measurements are highly dependent on 
uniform BHs, correct delineation and especially the basal 
slice will have a major contribution to the results, and it 
is thus important whether it is included in the blood pool 
or not, though the slice may be precisely in the mitral 
valve.
Turbulence and complex flow
A previous study has speculated that the systematic differ-
ence between flow and volumetric measurements could be 
caused by the different physiology during BH used for cine 
sequences versus FB used for flow sequences.8 The present 
study contradicts this hypothesis because FB and BH flow 
sequences produce similar results, suggesting that the 
observed differences between volumetric and 2D PC flow 
measurement may be an inherent problem with the 2D PC 
flow method. The flow pattern in the ascending aorta is 
complex, though under normal conditions approximately 
laminar until late systole where it forms a right- handed 
helix pattern as well as vortical flow (flow resolving around 
an axis) in the sinus of Valsalva. In patients with patho-
logical conditions, the flow becomes more complex and 
forms turbulence, acceleration and a more pronounced 
vortical and helical flow pattern.31 As 2D PC flow is only 
measuring flow in one plane, it is prone to underestima-
tion and complex flow patterns will result in lower volumes 
measured. Several studies have found clearly reduced 
Figure 3 Bland- Altman plots volumetric vs flow measurements. The continuous line represents the mean and the dotted line 
represent the 95% limits of agreement for SV measured with FB and BH flow, respectively, at indicated place compared with 
corresponding volumetric measurement. Dotted red line indicates no bias. (A, E) Valve level. (B, F) ST junction. (C, G) Mid- 
ascending aorta. (D, H) Pulmonary artery. Corresponding paired t- tests are indicated. In left- sided measurements, patients with 
mitral regurgitation have been excluded (n=30). In right- sided measurements patients with tricuspid regurgitation have been 
excluded (n=26). BH, breath- hold; FB, free- breathing; ST, sinotubular; SV, stroke volume.
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measured 2D PC aortic flow in patients with increased 
turbulence,5 6 8 while as demonstrated by Nordmeyer et al, 
this is not a problem with 4D flow in healthy volunteers.31 
The found reduction in measured SV may very well be a 
result of increasing turbulence with increasing distance 
to the valve, even in healthy subjects. 4D flow further-
more allows direct quantification of regurgitant volumes 
employing a dynamic measurement plane by tracking the 
mitral annulus throughout the cardiac cycle.32 Studies 
suggest31 33 that 4D flow measurements could possibly solve 
many of the issues addressed in the present paper, but 
besides requiring extensive training, 4D flow is currently 
not commercially available on all scanners.
In 2D PC imaging, it is very important that flow is 
perpendicular to the imaging slice. Valve images and 
ST- junction images were carefully planned orthogonally 
to aorta whereas the mid- ascending images were copied 
from the axial stack and hence could result in some 
angulation to the aorta. This would be expected to be 
within ±15 degrees that should be compensated for by 
the simultaneous increase in vessel area and increase in 
partial volume effects,29 34 thereby not causing the lower 
SV measured at the mid- ascending aorta.
Clinical flow measurements
For a clinical workflow, the optimal flow assessment should 
have no phase offset error and should require very little 
post- processing work. Intuitively, the mid- ascending aorta 
seems the obvious choice. However, as indicated by the 
present study, in choosing such a distal image position 
in the aorta, one also introduces a significant systematic 
error. This was evident for FB as well as BH sequences. 
Essential to this point, our study provides a best- case 
scenario since the subjects in the present study were all 
healthy. Nevertheless, flow measurements systematically 
decrease in aorta and result in increasing overestimation 
of mitral regurgitation of up to 15%. Structural abnor-
malities in the aortic valve or ascending aorta, which are 
often present in patients referred for CMR, may intro-
duce even larger errors.5 6 It is unpredictable how large 
the loss of SV due to turbulence in each case will be and 
it can therefore not simply be corrected for by adding the 
approximated ‘lost volume’.
When studying atrioventricular valve regurgitations 
using CMR, we therefore recommend that
 ► Multiple CMR techniques are used in order to get a 
detailed description of the condition and a reliable 
conclusion.9
 ► Flow is reported as a mean of at least two consecu-
tive acquisitions due to the possible errors in flow 
measurements.
 ► Flow measurements in the mid- ascending aorta are 
avoided or used with caution.
 ► Background correction is applied and the effect on 
the results evaluated.
Limitations
All scans were performed on a Siemens Aera scanner, and 
results could vary on other magnetic resonance scanners.
PC sequence parameters for FB and BH were not 
identical (table 2) which may impact the comparison 
between these methods. The sequences used corre-
spond to clinical scans, and the results are hence clin-
ically applicable.
A limitation of the present study is the use of the volu-
metric assessment as reference. As described previously, 
this similarly applies to the indirect method.
We only performed flow in the pulmonary trunk at 
one level and cannot say whether flow signal changes 
throughout the pulmonary trunk.
Figure 4 Measured stroke volumes and corresponding 
calculated ‘false’ regurgitant fraction. Mean stroke volumes 
measured volumetrically in left (LVvol) and right (RVvol) 
ventricle and with FB and BH flow at valve level (flow 
valve), sinotubular junction (flow ST), mid- ascending aorta 
(flow MA) and the pulmonary artery (flow PA). In left- sided 
measurements (LVvol, flow valve, flow ST and flow MA), 
patients with mitral regurgitation have been excluded (n=30). 
In right- sided measurements (RVvol and flow PA), patients 
with tricuspid regurgitation have been excluded (n=26). 
Results are summarised in online supplementary table 
S2. Note that LV volumetric and flow at valve level should 
theoretically be similar, but that flow at the ST junctions is 
expected to be 5% lower because of the coronary arteries. 
A further fall at the mid- ascending aorta is not expected. 
The RV- volumetric and pulmonary flow should theoretically 
be similar as well. Below the x- axis are the corresponding 
calculated atrioventricular regurgitation fractions. Regurgitant 
volume is calculated by subtracting forward phase contrast 
flow in aorta at specified measurements level from the 
volumetric segmentation. *p=0.01, **p<0.001, ***p<0.0001. 
BH, breath- hold flow; FB, free- breathing flow; LV, left 
ventricle; RV, right ventricle; ST, sinotubular.
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CONCLUSION
Mitral regurgitations are systematically overestimated by 
the indirect method combining CMR PC flow and volu-
metric segmentations. The overestimation ranged from 
8.0% at valve level to 12% at the ST junction, and 15% at 
the mid- ascending aorta in participants with no abnormali-
ties of the large vessels and no visible atrioventricular regur-
gitations. There were no differences between BH and FB 
sequences.
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